Valuation RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Real-time Estimate
Cboe Europe
12:51:34 14/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 190.30 SEK | -0.21% |
|
+7.93% | -16.45% |
| 09:22pm | RaySearch Laboratories AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07:33pm | EFN: A ketchup effect worth waiting for at RaySearch | FW |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 6,538 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -16.36% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 6,707 | 6,563 | 6,344 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -14.06% | -2.15% | -3.34% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 24.4x | 20x | 16.2x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 7.36x | 6.05x | 4.97x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1.4x | 0.9x | 0.7x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 4.68x | 4.01x | 3.54x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 4.8x | 4.02x | 3.44x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 10.4x | 8.83x | 7.34x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 19.2x | 15.1x | 11.7x |
| EV / FCF | 234x | - | - | - | 21.7x | 37.7x | 23.2x | 16.7x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 2.65% | 4.31% | 5.97% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 4.76 | 5.87 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 2.1% | 2.5% | 3.08% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 7.8 | 9.52 | 11.74 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 51.3% | 50% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,396 | 1,630 | 1,846 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 643 | 743.5 | 864 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 348.5 | 435 | 544.5 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 265 | 320 | 394 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | 169 | 25 | -194 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 190.70 | 190.70 | 190.70 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | - | - |
| Announcement Date | 23/2/22 | 28/2/23 | 23/2/24 | 21/2/25 | 12/2/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.45x | 4.8x | 10.43x | 2.1% | 685M | |
| 37.75x | 8.79x | 19.46x | -.--% | 39.23B | |
| 83.24x | 71.81x | 89.46x | 0.42% | 13.43B | |
| 82.27x | 12.14x | 52.68x | 0.71% | 5.65B | |
| -35.75x | 10.61x | -57.5x | - | 2.57B | |
| -6.47x | 61.69x | -6.62x | - | 1.94B | |
| 37.76x | - | - | -.--% | 1.69B | |
| -106.72x | - | - | - | 1B | |
| 6.2x | - | - | - | 908M | |
| -77.68x | 1128.76x | -105.37x | -.--% | 868M | |
| Average | 4.51x | 185.52x | 0.36x | 0.54% | 6.8B | |
| Weighted average by Cap. | 42.23x | 38.96x | 31.34x | 0.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
